Quiet reflection after effective action: hepatitis B viraemia and hepatocellular carcinoma recurrence.
Abdo
Ayman A
AA
Sanai
Faisal M
FM
D000998:Antiviral Agents / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000401:mortality / Q000473:pathology / Q000601:surgery* / Q000821:virology; D005260:Female; D006498:Hepatectomy / Q000009:adverse effects / Q000379:methods; D019694:Hepatitis B, Chronic / Q000150:complications / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D008103:Liver Cirrhosis / Q000401:mortality / Q000601:surgery / Q000821:virology; D008113:Liver Neoplasms / Q000473:pathology / Q000601:surgery* / Q000821:virology; D008297:Male; D011183:Postoperative Complications / Q000175:diagnosis / Q000401:mortality; D011379:Prognosis; D012008:Recurrence; D018570:Risk Assessment; D016019:Survival Analysis; D014766:Viremia / Q000175:diagnosis* / Q000401:mortality
D000998:Antiviral Agents